BIOMAT Database Logo BIOMAT Database Logo

The glycogen synthase gene in NIDDM and hypertension. 1995

Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004276 DNA, Satellite Highly repetitive DNA sequences found in HETEROCHROMATIN, mainly near centromeres. They are composed of simple sequences (very short) (see MINISATELLITE REPEATS) repeated in tandem many times to form large blocks of sequence. Additionally, following the accumulation of mutations, these blocks of repeats have been repeated in tandem themselves. The degree of repetition is on the order of 1000 to 10 million at each locus. Loci are few, usually one or two per chromosome. They were called satellites since in density gradients, they often sediment as distinct, satellite bands separate from the bulk of genomic DNA owing to a distinct BASE COMPOSITION. Satellite DNA,Satellite I DNA,DNA, Satellite I,DNAs, Satellite,DNAs, Satellite I,I DNA, Satellite,I DNAs, Satellite,Satellite DNAs,Satellite I DNAs
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006006 Glycogen Synthase An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11. Glycogen (Starch) Synthase,Glycogen Synthetase,Glycogen Synthase I,Synthase D,Synthase I,UDP-Glucose Glycogen Glucosyl Transferase,Synthase, Glycogen,Synthetase, Glycogen,UDP Glucose Glycogen Glucosyl Transferase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph

Related Publications

Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
[Glycogen synthase gene-glycogen synthase gene in Japanese patients with NIDDM].
October 1994, Nihon rinsho. Japanese journal of clinical medicine,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland.
November 1997, Diabetologia,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
[Glycogen synthase gene].
October 1997, Nihon rinsho. Japanese journal of clinical medicine,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects.
May 1994, Diabetologia,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians.
March 1996, Diabetologia,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients.
December 1991, Diabetes,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
Glycogen synthase polymorphism, insulin resistance and hypertension.
March 1996, Blood pressure,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
[The muscle glycogen synthase gene mutation].
July 2002, Nihon rinsho. Japanese journal of clinical medicine,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
Impaired activation of glycogen synthase in people at increased risk for developing NIDDM.
May 1992, Diabetes,
Y Hamada, and H Ikegami, and Y Fujioka, and E Yamato, and K Takekawa, and T Fujisawa, and Y Nakagawa, and H Ueda, and J Fu, and G Q Shen
Increased concentrations of glycogen synthase protein in skeletal muscle of patients with NIDDM.
July 1995, The American journal of physiology,
Copied contents to your clipboard!